跳至主要内容
临床试验/EUCTR2019-004208-37-BE
EUCTR2019-004208-37-BE进行中(未招募)1 期

Drug repurposing - Statins as microbiota modulating agents in ulcerative colitis - ReMiDy

Z Leuven0 个研究点目标入组 400 人开始时间: 2020年3月4日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • General criteria
  • Bact2 enterotyped one month before start of study intervention (at least 150 of enrolled participants must meet this criteria)
  • Willingness to participate in the study and to sign the informed consent (Dutch)
  • Between 18 and 75 years old
  • Access to a -20°C freezer
  • Criteria specific to UC patients
  • Patients in remission (mayo score below 4) or with currently mild to moderate active ulcerative colitis (defined by Mayo score of 4-10), despite stable medication (8 weeks) and a Mayo endoscopic sub-score 2-3 at week 0
  • Criteria specific to healthy Bact2 participants
  • Individuals with no physician diagnosed diseases or disorders
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 300
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

排除标准

  • General criteria
  • Prior and/or ongoing use of statins before study start
  • History of surgical intervention in gastrointestinal tract
  • Females who are pregnant or actively trying to become pregnant
  • Individuals with active liver disease including unexplained persistent elevations of serum transaminases and any serum transaminases elevation exceeding three times the upper limit of normal (ULN)
  • Lactose intolerance
  • Pre-diabetic participants
  • Personal or family history of hereditary muscular disorders
  • Individuals with a history of or diagnosed with alcohol abuse
  • Criteria specific to UC patients
  • Other conditions leading to profound immunosuppression such as HIV, infectious diseases leading to immunosuppression, bone marrow malignancies, liver cirrhosis
  • A diagnosis of Crohn’s disease or indeterminate colitis
  • Individuals with hypothyroidism
  • Individuals with a diagnosis of diabetes mellitus
  • Individuals with severe renal impairment (creatinine clearance <30 ml/min)
  • Individuals with myopathy
  • Participants who have taken antibiotics sometime in the past four months
  • Use of antibiotics one month prior to week 0
  • Steroid dependency and requiring >16mg Medrol (methyl prednisone) or equivalent two week before week 0
  • Criteria specific to healthy Bact2 participants
  • Participants with family history of autoimmune chronic inflammatory diseases like multiple sclerosis, IBD, and rheumatoid arthritis

研究者

发起方
Z Leuven

相似试验

Statins for treating ulcerative colitis through GI... | 临床试验